A global biomedical R&D fund and mechanism for innovations of public health importance

* Anti-microbial resistance, emerging infectious diseases, and neglected diseases are all important public health concerns and priorities with serious market failures, deficits, and identified needs in biomedical innovation.

Saved in:
Bibliographic Details
Published inPLoS medicine Vol. 12; no. 5; p. e1001831
Main Authors Balasegaram, Manica, Bréchot, Christian, Farrar, Jeremy, Heymann, David, Ganguly, Nirmal, Khor, Martin, Lévy, Yves, Matsoso, Precious, Minghui, Ren, Pécoul, Bernard, Peilong, Liu, Tanner, Marcel, Røttingen, John-Arne
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.05.2015
Public Library of Science (PLoS)
Subjects
Antibiotics
Biomedical Research - economics
Biomedical Technology
Collaboration
Commercial markets
Ebola virus
Global Health
Health Priorities
Humans
Industrial research
Infectious diseases
Innovations
Management
Medical research
Public Health
Research Support as Topic - organization & administration
Technological change
United Kingdom
Working groups
United Kingdom
Online AccessGet full text

Cover

More Information
Summary:* Anti-microbial resistance, emerging infectious diseases, and neglected diseases are all important public health concerns and priorities with serious market failures, deficits, and identified needs in biomedical innovation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Wrote the first draft of the manuscript: MB JAR. Contributed to the writing of the manuscript: BP MK PM. Author Contributions: MB CB DH JF NG MK YL PM RM BP LP MT JAR. All authors have read, and confirm that they meet, ICMJE criteria for authorship.
The authors have declared that no competing interests exist.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.1001831